The impact of indomethacin on the number of oocytes retrieved and IVF outcomes in patients with poor ovarian response

Basit Öğe Kaydı
dc.authoridYAVUZ, ADEM/0000-0003-4191-4004
dc.authoridSonmezer, Murat/0000-0001-6101-1414
dc.contributor.authorYavuz, Adem
dc.contributor.authorOner, Gokalp
dc.contributor.authorTas, Mustafa
dc.contributor.authorSonmezer, Murat
dc.date.accessioned2024-11-07T13:35:00Z
dc.date.available2024-11-07T13:35:00Z
dc.date.issued2021
dc.departmentNiğde Ömer Halisdemir Üniversitesi
dc.description.abstractObjective: The aim of this retrospective case-control study was to analyze the effect of administering indomethacin after triggering final oocyte maturation in patients with poor ovarian response (POR) on the cycle cancellation rate due to premature ovulation (PO), the number of oocytes retrieved and the clinical outcomes of IVF cycles. Study Design: A total of 214 patients with POR, diagnosed according to the Bologna criteria, who underwent fresh IVF cycle via flexible gonadotrophin-releasing hormone antagonist (GnRH-ant) protocol were enrolled in the study. The control group consisted of 100 patients, whereas the indomethacin group included 114 patients who received 100 mg rectal indomethacin administered twice within the same day (twelve hours apart)-starting at twelve hours after triggering. Cycle cancelation rates (CCR), number of oocytes retrieved (nOR), implantation rates (IR), biochemical pregnancy (BP) and clinical pregnancy loss rates (CPL), ongoing pregnancy rates (OPR) and live birth rates (LBR) were compared between the indomethacin and control groups. Results: The CCR rate was significantly lower in the indomethacin group (1.8%) compared to the control group (1.8% vs %12%, p = 0.01). In the control group, those with cycle cancellation were older than those without cycle cancellation (mean age 42.2 +/- 2.3 years vs. 39.36 +/- 4.3 years, p = 0.001) and had lower anti-Mullerian hormone levels and lower antral follicle count (0.59 +/- 0.2 ng/mL vs 0.79 +/- 0.2 ng/mL, p = 0.001 and 4 +/- 0.6 vs 5.7 +/- 1.7, p = 0.001, respectively). In multivariable analysis, when the dependent variable in the logistic regression model was coded as the absence of cycle cancellation, it was observed that only indomethacin had a statistically significant effect on cycle cancellation (beta = -1.931, standard error = 0.832, Exp(B) = 0.145, p = 0.020). nOR was higher in the indomethacin group than control group but the difference did not reach significance (p = 0.07). Moreover, the IR, OPR and LBR, BP and CPL values were similar in the indomethacin and control groups (p > 0.05). Conclusions: Based on data from this study, it can be concluded that indomethacin reduces cycle cancelation due to PO in patients with POR -without compromising implantation and pregnancy rates. However, further randomized controlled trials with larger sample sizes are required to clarify the definitive effect of indomethacin in the treatment of patients with POR. (C) 2021 Elsevier B.V. All rights reserved.
dc.identifier.doi10.1016/j.ejogrb.2021.07.035
dc.identifier.endpage270
dc.identifier.issn0301-2115
dc.identifier.issn1872-7654
dc.identifier.pmid34340097
dc.identifier.scopus2-s2.0-85111524855
dc.identifier.scopusqualityN/A
dc.identifier.startpage266
dc.identifier.urihttps://doi.org/10.1016/j.ejogrb.2021.07.035
dc.identifier.urihttps://hdl.handle.net/11480/16271
dc.identifier.volume264
dc.identifier.wosWOS:000755157800048
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherElsevier
dc.relation.ispartofEuropean Journal of Obstetrics & Gynecology and Reproductive Biology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_20241106
dc.subjectIndomethacin
dc.subjectPoor ovarian response
dc.subjectIn vitro fertilization
dc.subjectPremature ovulation
dc.subjectCycle cancellation
dc.subjectLive birth rates
dc.titleThe impact of indomethacin on the number of oocytes retrieved and IVF outcomes in patients with poor ovarian response
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu